| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9429352 | Neuroscience Letters | 2005 | 6 Pages |
Abstract
Cranial irradiation (CI) confers remediation of many CNS anomalies. CI, however, carries risks to cognitive performance. A wealth of data describes such deficits specifically in humans. Risk factors that promote increased susceptibility to cognitive decline have also been identified. This paper discusses and grades these risk factors, including age, gender, and the inclusion of chemotherapy, that increase the likelihood of pathologic cognitive development in the human population.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Vahé Sarkissian,